The volume of the injections usually in the range of 0.2-1.0 ml. In the case of YpsoMate, a Ypsomed AG’s product, it is pressed against the skin and automatically starts the injection.
New York, NY -- (SBWIRE) -- 02/20/2017 -- Pharmaceuticals companies showing increasing trend towards self-injection delivery due to needle-stick prevention and dose accuracy. Also, patients need and convenience also contributing in growing demand for self-injection delivery system market. Self injection could be pen injectors, inhalers, disposable auto injectors etc. Autoinjector is a prefilled syringe that is integrated in the system which is suitable for all liquid stable drugs. The volume of the injections usually in the range of 0.2-1.0 ml. In the case of YpsoMate, a Ypsomed AG's product, it is pressed against the skin and automatically starts the injection. Cartridge-based pen injectors are usually used when the injection is required more than once in a week its volume need to be variable.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/11374
Some drugs are not liquid stable so they need to be served in a freeze dried state and then reconstituted with solvent prior to injection. Handling the device is very important as it may have negative effect on the product efficacy and also could put the treatment of the patient at risk. Hence it's important to handle the device carefully and avoid any risk of mishandling.
Increasing demand for self-injection devices, rising number of chronic disease, increasing diabetic patients, increase spending per capita income, are key driving factor for this market. Furthermore, rising growth of biologics market, technology advancement and innovation, are some other key driving factors in self-injection delivery system market. Furthermore, all the above mentioned factors has led to increase in demand of self-injection delivery system market in developed and developing regions.
With so many advantages and splendid features of self-injection delivery system, it has few disadvantages too. High cost and sterility of injections are acting as a barrier for self-injection delivery system market.
The self-injection delivery system market has grown substantially at a healthy CAGR due to increasing number of chronic disease. With rapid technological advancement and innovation, c self-injection delivery system market is expected to grow globally. North America is the largest market for self-injection delivery system and Asia Pacific would be the fastest growing market in the forecast period.
The self-injection delivery system market is expected to register a double-digit CAGR over the forecast period. Depending on geographic regions, self-injection delivery system market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, and Asia Pacific excluding Japan (APEJ), Japan, and Middle East & Africa (MEA). North America is the largest market for self-injection delivery system market and is expected to dominate the market throughout the forecast period. Asia Pacific is the fastest growing region in the forecast period.
Some of the key market players for self-injection delivery system market are Pfizer Inc., SCHOTT AG, Credence MedSystems, Inc., Dickinson and Company, West Pharmaceutical Services, Inc, SHL Group, Haselmeier AG, Gerresheimer Group, Alkermes, Eli Lilly and Company.
To View TOC of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/toc/11374
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.